Artificial Intelligence In Diagnostics Market
Artificial Intelligence In Diagnostics Market - Global Industry Assessment & Forecast
Segments Covered
- By Component Software, Hardware, Services
- By Therapeutic Area Oncology, Neurodegenerative Disease, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Other Areas
- By Application Drug Optimization & Repurposing, Preclinical Testing, Other Applications
- By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Base Year: | 2022 |
Forecast Years: | 2023 - 2030 |
Historical Years: | 2017 - 2021 |
Revenue 2022: | USD 1.1 Billion |
Revenue 2030: | USD 11.9 Billion |
Revenue CAGR (2023 - 2030): | 40.6% |
Fastest Growing Region (2023 - 2030) | Asia Pacific |
Largest Region (2022): | North America |
Customization Offered
- Cross-segment Market Size and Analysis for Mentioned Segments
- Additional Company Profiles (Upto 5 With No Cost)
- Additional Countries (Apart From Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request Customization Speak To Analyst
-
Executive Dashboard
- Strategic Imperatives
-
Premium Insights
- Top 3 Trends to Watch
- Demand and Supply Trends
- Top 3 Strategies Followed by Major Players
- Top 3 Predictions by Vantage Market Research
- Top Investment Pockets
- Insights from Primary Respondents
-
Global Artificial Intelligence In Diagnostics Market - Segment Analysis
- Overview
- Global Artificial Intelligence In Diagnostics Market, 2016 - 2028 (USD Million)
-
Global Artificial Intelligence In Diagnostics Market - by Component
- By Software
- By Hardware
- By Services
-
Global Artificial Intelligence In Diagnostics Market - by Therapeutic Area
- By Oncology
- By Neurodegenerative Disease
- By Cardiovascular Disease
- By Metabolic Disease
- By Infectious Disease
- By Other Areas
-
Global Artificial Intelligence In Diagnostics Market - by Application
- By Drug Optimization & Repurposing
- By Preclinical Testing
- By Other Applications
-
Global Artificial Intelligence In Diagnostics Market - by region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
- Market comparative analysis
-
North America Artificial Intelligence In Diagnostics Market - Segment Analysis
- Overview
- North America Artificial Intelligence In Diagnostics Market, 2016 - 2028 (USD Million)
-
North America Artificial Intelligence In Diagnostics Market, by Component
- By Software
- By Hardware
- By Services
-
North America Artificial Intelligence In Diagnostics Market, by Therapeutic Area
- By Oncology
- By Neurodegenerative Disease
- By Cardiovascular Disease
- By Metabolic Disease
- By Infectious Disease
- By Other Areas
-
North America Artificial Intelligence In Diagnostics Market, by Application
- By Drug Optimization & Repurposing
- By Preclinical Testing
- By Other Applications
-
North America Artificial Intelligence In Diagnostics Market, by Country
- U.S.
- U.S. Artificial Intelligence In Diagnostics Market, By Component
- By Software
- By Hardware
- By Services
- U.S. Artificial Intelligence In Diagnostics Market, By Therapeutic Area
- By Oncology
- By Neurodegenerative Disease
- By Cardiovascular Disease
- By Metabolic Disease
- By Infectious Disease
- By Other Areas
- U.S. Artificial Intelligence In Diagnostics Market, By Application
- By Drug Optimization & Repurposing
- By Preclinical Testing
- By Other Applications
- U.S. Artificial Intelligence In Diagnostics Market, By Component
- Canada
- Canada Artificial Intelligence In Diagnostics Market, By Component
- By Software
- By Hardware
- By Services
- Canada Artificial Intelligence In Diagnostics Market, By Therapeutic Area
- By Oncology
- By Neurodegenerative Disease
- By Cardiovascular Disease
- By Metabolic Disease
- By Infectious Disease
- By Other Areas
- Canada Artificial Intelligence In Diagnostics Market, By Application
- By Drug Optimization & Repurposing
- By Preclinical Testing
- By Other Applications
- Canada Artificial Intelligence In Diagnostics Market, By Component
- Mexico
- Mexico Artificial Intelligence In Diagnostics Market, By Component
- By Software
- By Hardware
- By Services
- Mexico Artificial Intelligence In Diagnostics Market, By Therapeutic Area
- By Oncology
- By Neurodegenerative Disease
- By Cardiovascular Disease
- By Metabolic Disease
- By Infectious Disease
- By Other Areas
- Mexico Artificial Intelligence In Diagnostics Market, By Application
- By Drug Optimization & Repurposing
- By Preclinical Testing
- By Other Applications
- Mexico Artificial Intelligence In Diagnostics Market, By Component
- U.S.
-
Europe Artificial Intelligence In Diagnostics Market - Segment Analysis
- Overview
- Europe Artificial Intelligence In Diagnostics Market, 2016 - 2028 (USD Million)
-
Europe Artificial Intelligence In Diagnostics Market, by Component
- By Software
- By Hardware
- By Services
-
Europe Artificial Intelligence In Diagnostics Market, by Therapeutic Area
- By Oncology
- By Neurodegenerative Disease
- By Cardiovascular Disease
- By Metabolic Disease
- By Infectious Disease
- By Other Areas
-
Europe Artificial Intelligence In Diagnostics Market, by Application
- By Drug Optimization & Repurposing
- By Preclinical Testing
- By Other Applications
-
Europe Artificial Intelligence In Diagnostics Market, by Country
- Germany
- Germany Artificial Intelligence In Diagnostics Market, By Component
- By Software
- By Hardware
- By Services
- Germany Artificial Intelligence In Diagnostics Market, By Therapeutic Area
- By Oncology
- By Neurodegenerative Disease
- By Cardiovascular Disease
- By Metabolic Disease
- By Infectious Disease
- By Other Areas
- Germany Artificial Intelligence In Diagnostics Market, By Application
- By Drug Optimization & Repurposing
- By Preclinical Testing
- By Other Applications
- Germany Artificial Intelligence In Diagnostics Market, By Component
- UK
- UK Market, By Component
- By Software
- By Hardware
- By Services
- UK Market, By Therapeutic Area
- By Oncology
- By Neurodegenerative Disease
- By Cardiovascular Disease
- By Metabolic Disease
- By Infectious Disease
- By Other Areas
- UK Market, By Application
- By Drug Optimization & Repurposing
- By Preclinical Testing
- By Other Applications
- UK Market, By Component
- France
- France Artificial Intelligence In Diagnostics Market, By Component
- By Software
- By Hardware
- By Services
- France Artificial Intelligence In Diagnostics Market, By Therapeutic Area
- By Oncology
- By Neurodegenerative Disease
- By Cardiovascular Disease
- By Metabolic Disease
- By Infectious Disease
- By Other Areas
- France Artificial Intelligence In Diagnostics Market, By Application
- By Drug Optimization & Repurposing
- By Preclinical Testing
- By Other Applications
- France Artificial Intelligence In Diagnostics Market, By Component
- Spain
- Spain Artificial Intelligence In Diagnostics Market, By Component
- By Software
- By Hardware
- By Services
- Spain Artificial Intelligence In Diagnostics Market, By Therapeutic Area
- By Oncology
- By Neurodegenerative Disease
- By Cardiovascular Disease
- By Metabolic Disease
- By Infectious Disease
- By Other Areas
- Spain Artificial Intelligence In Diagnostics Market, By Application
- By Drug Optimization & Repurposing
- By Preclinical Testing
- By Other Applications
- Spain Artificial Intelligence In Diagnostics Market, By Component
- Italy
- Italy Artificial Intelligence In Diagnostics Market, By Component
- By Software
- By Hardware
- By Services
- Italy Artificial Intelligence In Diagnostics Market, By Therapeutic Area
- By Oncology
- By Neurodegenerative Disease
- By Cardiovascular Disease
- By Metabolic Disease
- By Infectious Disease
- By Other Areas
- Italy Artificial Intelligence In Diagnostics Market, By Application
- By Drug Optimization & Repurposing
- By Preclinical Testing
- By Other Applications
- Italy Artificial Intelligence In Diagnostics Market, By Component
- BENELUX
- BENELUX Artificial Intelligence In Diagnostics Market, By Component
- By Software
- By Hardware
- By Services
- BENELUX Artificial Intelligence In Diagnostics Market, By Therapeutic Area
- By Oncology
- By Neurodegenerative Disease
- By Cardiovascular Disease
- By Metabolic Disease
- By Infectious Disease
- By Other Areas
- BENELUX Artificial Intelligence In Diagnostics Market, By Application
- By Drug Optimization & Repurposing
- By Preclinical Testing
- By Other Applications
- BENELUX Artificial Intelligence In Diagnostics Market, By Component
- Rest of Europe
- Rest Of Europe Artificial Intelligence In Diagnostics Market, By Component
- By Software
- By Hardware
- By Services
- Rest Of Europe Artificial Intelligence In Diagnostics Market, By Therapeutic Area
- By Oncology
- By Neurodegenerative Disease
- By Cardiovascular Disease
- By Metabolic Disease
- By Infectious Disease
- By Other Areas
- Rest Of Europe Artificial Intelligence In Diagnostics Market, By Application
- By Drug Optimization & Repurposing
- By Preclinical Testing
- By Other Applications
- Rest Of Europe Artificial Intelligence In Diagnostics Market, By Component
- Germany
-
Asia Pacific Artificial Intelligence In Diagnostics Market - Segment Analysis
- Overview
- Asia Pacific Artificial Intelligence In Diagnostics Market, 2016 - 2028 (USD Million)
-
Asia Pacific Artificial Intelligence In Diagnostics Market, by Component
- By Software
- By Hardware
- By Services
-
Asia Pacific Artificial Intelligence In Diagnostics Market, by Therapeutic Area
- By Oncology
- By Neurodegenerative Disease
- By Cardiovascular Disease
- By Metabolic Disease
- By Infectious Disease
- By Other Areas
-
Asia Pacific Artificial Intelligence In Diagnostics Market, by Application
- By Drug Optimization & Repurposing
- By Preclinical Testing
- By Other Applications
-
Asia Pacific Artificial Intelligence In Diagnostics Market, by Country
- China
- China Artificial Intelligence In Diagnostics Market, By Component
- By Software
- By Hardware
- By Services
- China Artificial Intelligence In Diagnostics Market, By Therapeutic Area
- By Oncology
- By Neurodegenerative Disease
- By Cardiovascular Disease
- By Metabolic Disease
- By Infectious Disease
- By Other Areas
- China Artificial Intelligence In Diagnostics Market, By Application
- By Drug Optimization & Repurposing
- By Preclinical Testing
- By Other Applications
- China Artificial Intelligence In Diagnostics Market, By Component
- Japan
- Japan Artificial Intelligence In Diagnostics Market, By Component
- By Software
- By Hardware
- By Services
- Japan Artificial Intelligence In Diagnostics Market, By Therapeutic Area
- By Oncology
- By Neurodegenerative Disease
- By Cardiovascular Disease
- By Metabolic Disease
- By Infectious Disease
- By Other Areas
- Japan Artificial Intelligence In Diagnostics Market, By Application
- By Drug Optimization & Repurposing
- By Preclinical Testing
- By Other Applications
- Japan Artificial Intelligence In Diagnostics Market, By Component
- India
- India Artificial Intelligence In Diagnostics Market, By Component
- By Software
- By Hardware
- By Services
- India Artificial Intelligence In Diagnostics Market, By Therapeutic Area
- By Oncology
- By Neurodegenerative Disease
- By Cardiovascular Disease
- By Metabolic Disease
- By Infectious Disease
- By Other Areas
- India Artificial Intelligence In Diagnostics Market, By Application
- By Drug Optimization & Repurposing
- By Preclinical Testing
- By Other Applications
- India Artificial Intelligence In Diagnostics Market, By Component
- South Korea
- South Korea Artificial Intelligence In Diagnostics Market, By Component
- By Software
- By Hardware
- By Services
- South Korea Artificial Intelligence In Diagnostics Market, By Therapeutic Area
- By Oncology
- By Neurodegenerative Disease
- By Cardiovascular Disease
- By Metabolic Disease
- By Infectious Disease
- By Other Areas
- South Korea Artificial Intelligence In Diagnostics Market, By Application
- By Drug Optimization & Repurposing
- By Preclinical Testing
- By Other Applications
- South Korea Artificial Intelligence In Diagnostics Market, By Component
- South East Asia
- South East Asia Artificial Intelligence In Diagnostics Market, By Component
- By Software
- By Hardware
- By Services
- South East Asia Artificial Intelligence In Diagnostics Market, By Therapeutic Area
- By Oncology
- By Neurodegenerative Disease
- By Cardiovascular Disease
- By Metabolic Disease
- By Infectious Disease
- By Other Areas
- South East Asia Artificial Intelligence In Diagnostics Market, By Application
- By Drug Optimization & Repurposing
- By Preclinical Testing
- By Other Applications
- South East Asia Artificial Intelligence In Diagnostics Market, By Component
- Rest of Asia Pacific
- Rest of Asia Pacific Artificial Intelligence In Diagnostics Market, By Component
- By Software
- By Hardware
- By Services
- Rest of Asia Pacific Artificial Intelligence In Diagnostics Market, By Therapeutic Area
- By Oncology
- By Neurodegenerative Disease
- By Cardiovascular Disease
- By Metabolic Disease
- By Infectious Disease
- By Other Areas
- Rest of Asia Pacific Artificial Intelligence In Diagnostics Market, By Application
- By Drug Optimization & Repurposing
- By Preclinical Testing
- By Other Applications
- Rest of Asia Pacific Artificial Intelligence In Diagnostics Market, By Component
- China
-
Latin America Artificial Intelligence In Diagnostics Market - Segment Analysis
- Overview
- Latin America Artificial Intelligence In Diagnostics Market, 2016 - 2028 (USD Million)
-
Latin America Artificial Intelligence In Diagnostics Market, by Component
- By Software
- By Hardware
- By Services
-
Latin America Artificial Intelligence In Diagnostics Market, by Therapeutic Area
- By Oncology
- By Neurodegenerative Disease
- By Cardiovascular Disease
- By Metabolic Disease
- By Infectious Disease
- By Other Areas
-
Latin America Artificial Intelligence In Diagnostics Market, by Application
- By Drug Optimization & Repurposing
- By Preclinical Testing
- By Other Applications
-
Latin America Artificial Intelligence In Diagnostics Market, by Country
- Brazil
- Brazil Artificial Intelligence In Diagnostics Market, By Component
- By Software
- By Hardware
- By Services
- Brazil Artificial Intelligence In Diagnostics Market, By Therapeutic Area
- By Oncology
- By Neurodegenerative Disease
- By Cardiovascular Disease
- By Metabolic Disease
- By Infectious Disease
- By Other Areas
- Brazil Artificial Intelligence In Diagnostics Market, By Application
- By Drug Optimization & Repurposing
- By Preclinical Testing
- By Other Applications
- Brazil Artificial Intelligence In Diagnostics Market, By Component
- Argentina
- Argentina Artificial Intelligence In Diagnostics Market, By Component
- By Software
- By Hardware
- By Services
- Argentina Artificial Intelligence In Diagnostics Market, By Therapeutic Area
- By Oncology
- By Neurodegenerative Disease
- By Cardiovascular Disease
- By Metabolic Disease
- By Infectious Disease
- By Other Areas
- Argentina Artificial Intelligence In Diagnostics Market, By Application
- By Drug Optimization & Repurposing
- By Preclinical Testing
- By Other Applications
- Argentina Artificial Intelligence In Diagnostics Market, By Component
- Rest of Latin America
- Rest of Latin America Artificial Intelligence In Diagnostics Market, By Component
- By Software
- By Hardware
- By Services
- Rest of Latin America Artificial Intelligence In Diagnostics Market, By Therapeutic Area
- By Oncology
- By Neurodegenerative Disease
- By Cardiovascular Disease
- By Metabolic Disease
- By Infectious Disease
- By Other Areas
- Rest of Latin America Artificial Intelligence In Diagnostics Market, By Application
- By Drug Optimization & Repurposing
- By Preclinical Testing
- By Other Applications
- Rest of Latin America Artificial Intelligence In Diagnostics Market, By Component
- Brazil
-
Middle East & Africa Artificial Intelligence In Diagnostics Market - Segment Analysis
- Overview
- Middle East & Africa Artificial Intelligence In Diagnostics Market, 2016 - 2028 (USD Million)
-
Middle East & Africa Artificial Intelligence In Diagnostics Market, by Component
- By Software
- By Hardware
- By Services
-
Middle East & Africa Artificial Intelligence In Diagnostics Market, by Therapeutic Area
- By Oncology
- By Neurodegenerative Disease
- By Cardiovascular Disease
- By Metabolic Disease
- By Infectious Disease
- By Other Areas
-
Middle East & Africa Artificial Intelligence In Diagnostics Market, by Application
- By Drug Optimization & Repurposing
- By Preclinical Testing
- By Other Applications
-
Middle East & Africa Artificial Intelligence In Diagnostics Market, by Country
- GCC Countries
- GCC Countries Artificial Intelligence In Diagnostics Market, By Component
- By Software
- By Hardware
- By Services
- GCC Countries Artificial Intelligence In Diagnostics Market, By Therapeutic Area
- By Oncology
- By Neurodegenerative Disease
- By Cardiovascular Disease
- By Metabolic Disease
- By Infectious Disease
- By Other Areas
- GCC Countries Artificial Intelligence In Diagnostics Market, By Application
- By Drug Optimization & Repurposing
- By Preclinical Testing
- By Other Applications
- GCC Countries Artificial Intelligence In Diagnostics Market, By Component
- South Africa
- South Africa Artificial Intelligence In Diagnostics Market, By Component
- By Software
- By Hardware
- By Services
- South Africa Artificial Intelligence In Diagnostics Market, By Therapeutic Area
- By Oncology
- By Neurodegenerative Disease
- By Cardiovascular Disease
- By Metabolic Disease
- By Infectious Disease
- By Other Areas
- South Africa Artificial Intelligence In Diagnostics Market, By Application
- By Drug Optimization & Repurposing
- By Preclinical Testing
- By Other Applications
- South Africa Artificial Intelligence In Diagnostics Market, By Component
- Rest of Middle East & Africa
- Rest of Middle East & Africa Artificial Intelligence In Diagnostics Market, By Component
- By Software
- By Hardware
- By Services
- Rest of Middle East & Africa Artificial Intelligence In Diagnostics Market, By Therapeutic Area
- By Oncology
- By Neurodegenerative Disease
- By Cardiovascular Disease
- By Metabolic Disease
- By Infectious Disease
- By Other Areas
- Rest of Middle East & Africa Artificial Intelligence In Diagnostics Market, By Application
- By Drug Optimization & Repurposing
- By Preclinical Testing
- By Other Applications
- Rest of Middle East & Africa Artificial Intelligence In Diagnostics Market, By Component
- GCC Countries
-
Key Market Dynamics
- Introduction
- Market Drivers
- Market Restraints
- Market Opportunities
- Porter's Five Forces Analysis
- PEST Analysis
- Regulatory Landscape
- Technology Landscape
- Regional Market Trends
-
COVID 19 Impact Analysis
- Key strategies undertaken by companies to tackle COVID-19
- Short term dynamics
- Long term dynamics
-
Marketing Stratagy Analysis
- Marketing Channel
- Direct Marketing
- Indirect Marketing
- Marketing Channel Development Trends
-
Competative Landscape
- Competition Matrix - 2021
- Company Market Share Analysis - 2021
- Key Company Activities, 2018 - 2021
- Strategic Developments - Heat Map Analysis
- Company Offering Evaluation
- Company Regional Presence Evaluation
-
Company Profiles
- Aidoc (U.S.)
- AliveCor Inc. (U.S.)
- Vuni Inc. (U.S.)
- Digital Diagnostics Inc. (U.S.)
- Siemens Healthineers (Germany)
- Neural Analytics (U.S.)
- Riverain Technologies (U.S.)
- Zebra Medical Vision Inc. (Israel)
- GE Healthcare (U.S.)
- Imagen Technologies (U.S.)
- Key Primary Respondents - VERBATIM
- Discussion Guide
- Customization Offered
- Annexure
- List of Figures
- List of Tables
- List of Abbreviations
FAQ
Frequently Asked Question
What is the global demand for Artificial Intelligence In Diagnostics in terms of revenue?
-
The global Artificial Intelligence In Diagnostics valued at USD 1.1 Billion in 2022 and is expected to reach USD 11.9 Billion in 2030 growing at a CAGR of 40.6%.
Which are the prominent players in the market?
-
The prominent players in the market are Aidoc (U.S.), AliveCor Inc. (U.S.), Vuni Inc. (U.S.), Digital Diagnostics Inc. (U.S.), Siemens Healthineers (Germany), Neural Analytics (U.S.), Riverain Technologies (U.S.), Zebra Medical Vision Inc. (Israel), GE Healthcare (U.S.), Imagen Technologies (U.S.).
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 40.6% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Artificial Intelligence In Diagnostics include
- Growing Need to Incorporate AI into Medical Diagnosis
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Artificial Intelligence In Diagnostics in 2022.